Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exiqon Introduces microRNA qPCR Panels for Stem Cell Research

Published: Wednesday, April 18, 2012
Last Updated: Wednesday, April 18, 2012
Bookmark and Share
Scientists to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

Exiqon A/S has launched microRNA qPCR panels for stem cell research.
The new Stem Cell Focus microRNA PCR Panels allow scientists interested in stem cell research to apply a panel of qPCR microRNA assays optimized for embryonic and induced pluripotent research.

The 85 qPCR and 11 control assays have been experimentally optimized and validated to fit the needs of researchers interested in differentiation, proliferation, development and homeostasis of stem cells.

Recent research has documented the importance of microRNAs in the differentiation of stem cells as microRNAs are directly involved in determining the fate of the undifferentiated stem cells and in the process of inducing pluripotency of differentiated cells.

The Stem Cell Focus microRNA PCR Panels offered by Exiqon are perfectly suited for testing the degree and type of differentiation as well as the quality of the differentiation.

In a comment, Senior Vice President Sales & Marketing Henrik M. Pfundheller said: “We understand from our customers that they only have access to very limited sample material. We are therefore offering a product that only requires a 10 µl reaction volume and can detect down to 5 copies of microRNAs which is unprecedented in the market”.

He added: “Also microRNAs with high sequence content of A and T that are normally hard to detect are readily detected due to the inclusion of LNA™ in the PCR primers”.

The Stem Cell Focus microRNA PCR Panels are based on the most sensitive microRNA qPCR platform available with required sample input of as little as 1 pg of total RNA without any need for pre-amplification and thus avoiding risk of introducing bias in the generation of cDNA due to the unique universal RT step.

All major brands of qPCR instruments are supported by the Stem Cell Focus microRNA PCR Panels including instruments for both 96 and 384 well array formats.

The Stem Cell Focus microRNA PCR Panels are fully compatible with all other products in the miRCURY LNA™ Universal RT microRNA PCR system product line including the data analysis software. The entire work process from sample to data can be completed in 3 hours.

Exiqon offers a complete range of PCR products for the microRNA analysis which includes ready-to-use panels for genome-wide screening of human, mouse and rat microRNAs, numerous other focus panels, the fully flexible Pick & Mix panels, spike in kits, as well as RT and Master Mix kits, sample preparation and a unique qPCR data analysis software.

If customers have identified proprietary microRNAs and would like to take advantage of Exiqon’s proprietary LNA™ chemistry and unique RT technology, Exiqon also offers an easy to use design software for high quality design of custom microRNA qPCR assays.

The miRCURY LNA™ microRNA PCR is also accessible via Exiqon Services.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Rapidly Generating Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
New Mechanism of Tuberculosis Infection
Researchers have identified a new infection mechanism of tuberculosis that could lead to a new therapeutic angle.
Modelling ALS Requires ‘Aged’ Stem Cells
Research suggests engineered cells are too ‘young’ to accurately model ALS and should be 'aged' to speed progress toward finding potential treatments.
Protein Reinforces Growth of Damaged Muscles
Biologists have found a protein involved in stem cells that bolsters damaged muscle tissue growth - potential for muscle degeneration treatments.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
HIV Hides No Longer
Researchers are working to create proteins that clear HIV-infected cells in order to eliminate latent infection and dormancy.
R&D Agreement for Development of CtDNA Diagnostics
SeraCare and NIST partner for development of ctDNA diagnostic assay reference materials.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!